U.S. Markets closed
  • S&P Futures

    3,849.75
    +15.50 (+0.40%)
     
  • Dow Futures

    30,998.00
    +89.00 (+0.29%)
     
  • Nasdaq Futures

    13,455.25
    +93.75 (+0.70%)
     
  • Russell 2000 Futures

    2,171.70
    +7.70 (+0.36%)
     
  • Crude Oil

    52.20
    -0.07 (-0.13%)
     
  • Gold

    1,854.60
    -1.60 (-0.09%)
     
  • Silver

    25.66
    +0.10 (+0.41%)
     
  • EUR/USD

    1.2176
    +0.0001 (+0.0122%)
     
  • 10-Yr Bond

    1.0910
    -0.0180 (-1.62%)
     
  • Vix

    21.91
    +0.59 (+2.77%)
     
  • GBP/USD

    1.3694
    +0.0010 (+0.0740%)
     
  • USD/JPY

    103.7700
    +0.0090 (+0.0087%)
     
  • BTC-USD

    32,757.80
    -31.52 (-0.10%)
     
  • CMC Crypto 200

    669.24
    +59.25 (+9.71%)
     
  • FTSE 100

    6,695.07
    -20.35 (-0.30%)
     
  • Nikkei 225

    28,749.62
    +118.17 (+0.41%)
     

Brazil close to buying 100 mln doses of China's CoronaVac vaccine from Butantan

·1 min read

BRASILIA, Jan 7 (Reuters) - Brazil is in the process of closing a deal for up to 100 million doses of the COVID-19 vaccine developed by China's Sinovac Biotech and finished in Brazil by Sao Paulo's Butantan biomedical center, the health minister said Thursday.

Health Minister Eduardo Pazuello said the Chinese vaccine, called CoronaVac, will be included in Brazil's national immunization plan, along with 100 million doses of AstraZeneca's vaccine, to be finished at federal biomedical center Fiocruz and delivered by June.

Speaking at a news conference, Pazuello said liability, production and sovereignty issues were preventing Brazil from reaching a deal to buy doses of a COVID-19 vaccine made by Pfizer. (Reporting by Anthony Boadle and Gabriel Stargardter Editing by Brad Haynes)